The science
The serum's evidence is strongest for the ingredients it does not advertise and weakest for the one it does. Niacinamide in second place is the best-supported active: a 2002 randomised, vehicle-controlled study in the British Journal of Dermatology showed that topical niacinamide reduced cutaneous pigmentation by suppressing melanosome transfer to keratinocytes, and the wider literature at 2 to 5 percent documents increased ceramide synthesis, reduced transepidermal water loss and improvement in fine lines and tone over eight to twelve weeks; the position here is consistent with a dose in that range, though CeraVe does not disclose it. The three ceramides with cholesterol and phytosphingosine follow the physiological lipid ratio the brand's platform is built on, and ceramide-containing moisturizers have documented benefit for barrier function and hydration in atopic and dry skin, though the concentrations in a serum are modest and the one-hour barrier figure is the brand's own same-day measurement, not published data. Vitamin B12 is the surprising inclusion with genuine support: a 2004 randomised, placebo-controlled trial in the British Journal of Dermatology found topical vitamin B12 cream improved atopic dermatitis with good tolerability, and a 2017 trial in Dermatologic Therapy found a B12 barrier cream superior to a standard glycerol-petrolatum emollient in atopic dermatitis; both used a 0.07 percent cream applied twice daily, and the dose here, by position, is likely lower. Capryloyl salicylic acid is L'Oréal's lipohydroxy acid, with company-generated data on gentle exfoliation and limited independent literature. The peptide, acetyl dipeptide-1 cetyl ester, appears in the sensitive-skin ingredient reviews, including a 2022 review in the International Journal of Cosmetic Science of active ingredients for sensitive skin and a 2021 review in Pharmaceuticals of synthetic peptides in cosmetics for sensitive skin, as a soothing agent that reduces neurogenic discomfort; it has no independent evidence as an anti-aging or collagen-signalling peptide, and its position near the end of the list argues against any such role. Sodium hyaluronate at twenty-fifth is a surface humectant. No study of this 2026 serum has been published.
References 5 ShowHide
- The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer — British Journal of Dermatology (2002)
- Topical vitamin B12--a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial — British Journal of Dermatology (2004)
- Superiority of a vitamin B12-barrier cream compared with standard glycerol-petrolatum-based emollient cream in the treatment of atopic dermatitis: A randomized, left-to-right comparative trial — Dermatologic Therapy (2017)
- Sensitive skin: Active ingredients on the spotlight — International Journal of Cosmetic Science (2022)
- Usage of Synthetic Peptides in Cosmetics for Sensitive Skin — Pharmaceuticals (2021)